Insulin Resistance Syndrome: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>Kelly Patterson
No edit summary
imported>Pierre-Alain Gouanvic
(Redirecting to Metabolic syndrome)
 
(2 intermediate revisions by 2 users not shown)
Line 1: Line 1:
The '''insulin resistance syndrome''' is a "constellation of findings, including [[central obesity]], [[glucose intolerance]], [[dyslipidemia]], and [[hypertension]], that promotes the development of [[type 2 diabetes mellitus]], [[cardiovascular disease]], [[Cancer|cancer]], [[polycystic ovary syndrome|polysystic ovary syndrome]] (PCOS), and nonalcoholic fatty liver disease".(reference for quote: Sudha B. Biddinger & C. Ronald Kahn : FROM MICE TO MEN: Insights into the Insulin Resistance Syndromes.Annual Review of Physiology Vol. 68: 123-158 (Volume publication date January 2006) (doi:10.1146/annurev.physiol.68.040104.124723)). As [[Obesity|obesity]] has reached epidemic proportions in many countries of the developed world, a pattern of these findings has become recognized. Also called the metabolic syndrome, the dysmetabolic syndrome, or syndrome, this association of [[Physiology|physiologic findings]] is the focus of current research in [[medicine]].
#REDIRECT [[Metabolic syndrome]]
 
[[Category:CZ Live]]
 
[[Category:Health Sciences Workgroup]]

Latest revision as of 03:24, 17 November 2007

Redirect to:

Retrieved from "https://citizendium.org/wiki/index.php?title=Insulin_Resistance_Syndrome&oldid=13221"